US Bancorp’s Mirati Therapeutics, Inc. Common Stock MRTX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q1 | – | Sell |
-3,545
| Closed | -$208K | – | 4122 |
|
|
2023
Q4 | $208K | Buy |
3,545
+178
| +5% | +$10.5K | ﹤0.01% | 1986 |
|
|
2023
Q3 | $147K | Buy |
3,367
+2,272
| +207% | +$99K | ﹤0.01% | 1968 |
|
|
2023
Q2 | $39.6K | Sell |
1,095
-1,760
| -62% | -$63.6K | ﹤0.01% | 2597 |
|
|
2023
Q1 | $106K | Buy |
2,855
+1,014
| +55% | +$37.7K | ﹤0.01% | 2156 |
|
|
2022
Q4 | $83.4K | Sell |
1,841
-2,097
| -53% | -$95K | ﹤0.01% | 2270 |
|
|
2022
Q3 | $275K | Buy |
3,938
+569
| +17% | +$39.7K | ﹤0.01% | 1687 |
|
|
2022
Q2 | $227K | Buy |
3,369
+1,471
| +78% | +$99.1K | ﹤0.01% | 1826 |
|
|
2022
Q1 | $156K | Buy |
1,898
+1,478
| +352% | +$121K | ﹤0.01% | 2075 |
|
|
2021
Q4 | $63K | Sell |
420
-68
| -14% | -$10.2K | ﹤0.01% | 2521 |
|
|
2021
Q3 | $86K | Buy |
488
+216
| +79% | +$38.1K | ﹤0.01% | 2374 |
|
|
2021
Q2 | $44K | Buy |
272
+115
| +73% | +$18.6K | ﹤0.01% | 2728 |
|
|
2021
Q1 | $27K | Buy |
157
+72
| +85% | +$12.4K | ﹤0.01% | 2883 |
|
|
2020
Q4 | $19K | Buy |
85
+72
| +554% | +$16.1K | ﹤0.01% | 2929 |
|
|
2020
Q3 | $2K | Buy |
+13
| New | +$2K | ﹤0.01% | 3462 |
|
|
2020
Q1 | – | Sell |
-44
| Closed | -$6K | – | 3752 |
|
|
2019
Q4 | $6K | Sell |
44
-8
| -15% | -$1.09K | ﹤0.01% | 3199 |
|
|
2019
Q3 | $4K | Sell |
52
-172
| -77% | -$13.2K | ﹤0.01% | 3307 |
|
|
2019
Q2 | $23K | Buy |
224
+62
| +38% | +$6.37K | ﹤0.01% | 2831 |
|
|
2019
Q1 | $12K | Buy |
+162
| New | +$12K | ﹤0.01% | 3015 |
|